相似文献
1
Risks and benefits of anticoagulant therapy.
Semin Thromb Hemost. 1986 Jan;12(1):67-71. doi: 10.1055/s-2007-1003536.
2
Hemorrhagic complications of anticoagulant therapy.
Semin Thromb Hemost. 1986 Jan;12(1):39-57. doi: 10.1055/s-2007-1003533.
3
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176.
4
Effectiveness of anticoagulants.
Semin Thromb Hemost. 1986 Jan;12(1):21-37. doi: 10.1055/s-2007-1003532.
5
Risks of oral anticoagulant therapy with increasing age.
Arch Intern Med. 2005 Jul 11;165(13):1527-32. doi: 10.1001/archinte.165.13.1527.
6
[Current status of antithrombotic therapy].
Dtsch Med Wochenschr. 1995 Jan 27;120(4):105-10. doi: 10.1055/s-2008-1047737.
7
[Bleeding complications in oral anticoagulant treatment].
Nord Med. 1995;110(4):114-8.
8
Oral anticoagulant treatment with and without aspirin.
Thromb Haemost. 1995 Jul;74(1):506-10.
9
[Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation].
Med Clin (Barc). 1999 Mar 27;112(11):436-7.
10
Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Z Kardiol. 1986;75 Suppl 2:321-5.
Zotero 插件